
Sign up to save your podcasts
Or
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
đź’Š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
4.9
231231 ratings
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
đź’Š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
1,207 Listeners
334 Listeners
46 Listeners
68 Listeners
512 Listeners
279 Listeners
1,646 Listeners
370 Listeners
74 Listeners
60 Listeners
203 Listeners
191 Listeners
22 Listeners
103 Listeners
65 Listeners